文献速递神经肿瘤

原发性脑膜瘤中CD44表达升高:其临床意义及与瘤周脑水肿的关系

Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edema.
PubMed 文献 · J Neurosurg · 2024-02-09

研究对106例原发性脑膜瘤患者的冷冻肿瘤组织定量检测CD44基因表达,分析其与组织学恶性度、肿瘤体积及瘤周脑水肿(PTBE)的关系。结果显示WHO 2级和3级脑膜瘤CD44表达显著高于1级,CD44表达随PTBE严重程度增加,在1级或小肿瘤(最大径<43 mm)中重度PTBE(SC II或III)者CD44表达显著高于无或轻度PTBE(SC 0或I)者,多因素logistic回归显示CD44过表达是原发性脑膜瘤重度PTBE发生的独立显著因素。

要点

  • WHO 2级和3级脑膜瘤CD44基因表达显著高于1级脑膜瘤。
  • CD44表达随瘤周脑水肿(PTBE)严重程度增加而升高。
  • 多因素分析显示CD44过表达是原发性脑膜瘤重度PTBE的独立显著因素。

核心结论

  • 除肿瘤细胞侵袭性外,CD44表达促进脑膜瘤PTBE的发生;鉴于PTBE是脑膜瘤患者肿瘤相关癫痫或认知功能障碍的强因素,CD44是伴PTBE脑膜瘤的潜在治疗靶点。

研究设计与样本

  • 对106例原发性脑膜瘤患者手术获得的肿瘤组织行冷冻保存并定量检测CD44基因表达,分析其与组织学恶性度、肿瘤体积及PTBE的关系,PTBE采用Steinhoff分类(SC)系统(SC 0至SC III)评估。

主要发现

  • WHO 2级和3级脑膜瘤CD44基因表达显著高于1级脑膜瘤。
  • CD44表达随PTBE严重程度增加而升高。
  • 在1级脑膜瘤或小肿瘤(最大肿瘤直径<43 mm)中,重度PTBE(SC II或III)者CD44表达显著高于无或轻度PTBE(SC 0或I)者。
  • 多因素logistic回归分析显示CD44过表达是原发性脑膜瘤重度PTBE发生的独立显著因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: CD44 is a major cell surface receptor involved in cell adhesion and migration. The overexpression of CD44 is a poor prognostic factor in many neoplasms, including meningiomas. The aim of this study was to investigate the association between CD44 gene expression and clinical signatures of primary meningiomas. METHODS: CD44 gene expression was quantitatively evaluated by snap freezing tumor tissues obtained from 106 patients with primary meningioma. The relationships between CD44 expression and clinical signatures of meningiomas, including histological malignancy, tumor volume, and peritumoral brain edema (PTBE), were analyzed. PTBE was assessed using the Steinhoff classification (SC) system (from SC 0 to SC III). RESULTS: CD44 gene expression in WHO grade 2 and 3 meningiomas was significantly higher than that in grade 1 meningiomas. In addition, CD44 expression increased with the severity of PTBE. Particularly, among the grade 1 meningiomas or small-sized tumors (maximum tumor diameter < 43 mm), CD44 expression in tumors with severe PTBE (SC II or III) was significantly higher than that in tumors without or with mild PTBE (SC 0 or I). Multivariate logistic regression analysis also revealed that overexpression of CD44 was an independent significant factor of severe PTBE development in primary meningiomas. CONCLUSIONS: In addition to tumor cell aggressiveness, CD44 expression promotes the development of PTBE in meningioma. Since PTBE is a strong factor of tumor-related epilepsy or cognitive dysfunction in patients with meningioma, CD44 is thus a potential therapeutic target in meningioma with PTBE.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sawaya R, Yamaguchi S, Ishi Y, et al. Increased CD44 expression in primary meningioma: its clinical significance and association with peritumoral brain edema. J Neurosurg. 2024. PMID: 38335517. doi:10.3171/2023.11.JNS231884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。